179 related articles for article (PubMed ID: 37029804)
1. The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer.
van den Bovenkamp K; van der Vegt B; Halmos GB; Slagter-Menkema L; Langendijk JA; van Dijk BAC; Schuuring E; van der Laan BFAM
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3801-3809. PubMed ID: 37029804
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; de Bock GH; Langendijk JA; Kluin PM; Schuuring E; van der Laan BF; van der Wal JE
Laryngoscope; 2013 Sep; 123(9):2154-60. PubMed ID: 24167820
[TBL] [Abstract][Full Text] [Related]
4. Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy.
Douglas CM; Bernstein JM; Ormston VE; Hall RC; Merve A; Swindell R; Valentine HR; Slevin NJ; West CM; Homer JJ
Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):59-65. PubMed ID: 22841149
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.
Bernstein JM; Andrews TD; Slevin NJ; West CM; Homer JJ
Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150
[TBL] [Abstract][Full Text] [Related]
7. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
Hutchison GJ; Valentine HR; Loncaster JA; Davidson SE; Hunter RD; Roberts SA; Harris AL; Stratford IJ; Price PM; West CM
Clin Cancer Res; 2004 Dec; 10(24):8405-12. PubMed ID: 15623619
[TBL] [Abstract][Full Text] [Related]
10. Standardised Ki-67 proliferation index assessment in early-stage laryngeal squamous cell carcinoma in relation to local control and survival after primary radiotherapy.
Kop E; de Bock GH; Noordhuis MG; Slagter-Menkema L; van der Laan BFAM; Langendijk JA; Schuuring E; van der Vegt B
Clin Otolaryngol; 2020 Jan; 45(1):12-20. PubMed ID: 31561282
[TBL] [Abstract][Full Text] [Related]
11. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of immunohistochemical markers for oral tongue squamous cell carcinoma.
Hwa JS; Kwon OJ; Park JJ; Woo SH; Kim JP; Ko GH; Seo JH; Kim RB
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2953-9. PubMed ID: 25169079
[TBL] [Abstract][Full Text] [Related]
13. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
[TBL] [Abstract][Full Text] [Related]
14. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.
Brennan DJ; Jirstrom K; Kronblad A; Millikan RC; Landberg G; Duffy MJ; Rydén L; Gallagher WM; O'Brien SL
Clin Cancer Res; 2006 Nov; 12(21):6421-31. PubMed ID: 17085655
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
17. Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients.
Nordsmark M; Eriksen JG; Gebski V; Alsner J; Horsman MR; Overgaard J
Radiother Oncol; 2007 Jun; 83(3):389-97. PubMed ID: 17499868
[TBL] [Abstract][Full Text] [Related]
18. Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study.
Eriksen JG; Overgaard J;
Radiother Oncol; 2007 Jun; 83(3):383-8. PubMed ID: 17543403
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia contributes to development of recurrent endometrial carcinoma.
Pijnenborg JM; Wijnakker M; Hagelstein J; Delvoux B; Groothuis PG
Int J Gynecol Cancer; 2007; 17(4):897-904. PubMed ID: 17359291
[TBL] [Abstract][Full Text] [Related]
20. Expression and significance of hypoxia-inducible factor-1α and survivin in laryngeal carcinoma tissue and cells.
Li DW; Zhou L; Jin B; Xie J; Dong P
Otolaryngol Head Neck Surg; 2013 Jan; 148(1):75-81. PubMed ID: 23087365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]